Antonio Juan Más

780 total citations
24 papers, 405 citations indexed

About

Antonio Juan Más is a scholar working on Rheumatology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Juan Más has authored 24 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Juan Más's work include Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Antonio Juan Más is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Antonio Juan Más collaborates with scholars based in Spain, United States and Palestinian Territory. Antonio Juan Más's co-authors include Loreto Carmona, Rafael Martı́n-Granizo, Juana A. Flores‐Le Roux, Manuel Pera, Montserrat Villatoro, Albert Goday, Luís Grande, José M. Ramón, David Benaiges and Juan Pedro‐Botet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Antonio Juan Más

19 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Juan Más Spain 8 226 154 84 67 48 24 405
Bilge Başakçı Çalık Türkiye 11 83 0.4× 102 0.7× 37 0.4× 76 1.1× 29 0.6× 68 346
Avis Ware United States 5 312 1.4× 215 1.4× 13 0.2× 182 2.7× 32 0.7× 8 551
Samantha Stephens Canada 13 124 0.5× 52 0.3× 28 0.3× 35 0.5× 47 1.0× 27 515
Cheryl L. Wright United States 11 187 0.8× 164 1.1× 236 2.8× 12 0.2× 29 0.6× 19 630
T. Schochat Germany 9 150 0.7× 146 0.9× 69 0.8× 26 0.4× 20 0.4× 24 298
Joaquim Esteve-Vives Spain 10 310 1.4× 272 1.8× 48 0.6× 123 1.8× 32 0.7× 17 547
Frank R. van Genderen Netherlands 15 106 0.5× 76 0.5× 107 1.3× 12 0.2× 30 0.6× 17 726
T.L González Spain 4 243 1.1× 207 1.3× 23 0.3× 18 0.3× 15 0.3× 10 370
Tasmania del Pino‐Sedeño Spain 11 60 0.3× 25 0.2× 28 0.3× 30 0.4× 15 0.3× 36 317
J F Haverman Netherlands 6 201 0.9× 193 1.3× 10 0.1× 87 1.3× 18 0.4× 8 414

Countries citing papers authored by Antonio Juan Más

Since Specialization
Citations

This map shows the geographic impact of Antonio Juan Más's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Juan Más with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Juan Más more than expected).

Fields of papers citing papers by Antonio Juan Más

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Juan Más. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Juan Más. The network helps show where Antonio Juan Más may publish in the future.

Co-authorship network of co-authors of Antonio Juan Más

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Juan Más. A scholar is included among the top collaborators of Antonio Juan Más based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Juan Más. Antonio Juan Más is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collada, J. Molina, Marta Domínguez-Álvaro, R. González, et al.. (2025). Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry. Lara D. Veeken. 64(6). 3733–3738.
2.
Castañeda, Santos, Fernando Sánchez‐Alonso, Iván Ferraz‐Amaro, et al.. (2024). Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up. Seminars in Arthritis and Rheumatism. 66. 152442–152442. 4 indexed citations
3.
Bastidas, J. Augusto, et al.. (2024). Osseous sarcoidosis presenting as lytic and blastic bone lesions: A rare diagnostic challenge. SHILAP Revista de lepidopterología. 20(2). 1247–1251.
4.
Julià, Antonio, María López‐Lasanta, Francisco J. Blanco, et al.. (2021). Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskeletal Disorders. 22(1). 372–372. 12 indexed citations
5.
Ferrer, Carolina, Antonio Juan Más, Daniel Seoane‐Mato, et al.. (2020). Prevalence of fibromyalgia and associated factors in Spain.. PubMed. 38 Suppl 123(1). 47–52. 42 indexed citations
6.
Más, Antonio Juan, et al.. (2020). Diffuse idiopathic skeletal hyperostosis in a young woman treated with isotretinoin. Reumatología Clínica. 18(3). 184–185. 2 indexed citations
7.
Calvo-Río, V., O. Maíz, Ana Blanco, et al.. (2020). Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. Seminars in Arthritis and Rheumatism. 50(4). 608–615. 21 indexed citations
8.
Más, Antonio Juan, et al.. (2019). Adherence to Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study. Reumatología Clínica (English Edition). 15(5). 264–270. 1 indexed citations
9.
Calvo-Río, V., O. Maíz, E. Beltrán, et al.. (2017). AB0337 Biologic therapy in severe peripheral ulcerative keratitis (PUK). multicenter study of 27 patients. Annals of the Rheumatic Diseases. 76. 1166–1167. 1 indexed citations
10.
González‐Moreno, Juan, Mercedes García‐Gasalla, Inés Losada López, et al.. (2017). IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?. Rheumatology International. 38(2). 267–273. 14 indexed citations
11.
Más, Antonio Juan, et al.. (2017). Adherencia al tratamiento con fármacos moduladores de la enfermedad sintéticos en la artritis reumatoide. Resultados del estudio OBSERVAR. Reumatología Clínica. 15(5). 264–270. 3 indexed citations
12.
Clemente, Antonio, et al.. (2015). In vitro evaluation of γδ T cells regulatory function in Behçet’s disease patients and healthy controls. Human Immunology. 77(1). 20–28. 8 indexed citations
13.
Benaiges, David, Juana A. Flores‐Le Roux, Juan Pedro‐Botet, et al.. (2015). Predictors of Hypertension Remission and Recurrence After Bariatric Surgery. American Journal of Hypertension. 29(5). 653–659. 50 indexed citations
14.
Más, Antonio Juan, et al.. (2009). Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain.. PubMed. 26(4). 519–26. 208 indexed citations
15.
16.
17.
Más, Antonio Juan & J Rotès-Quérol. (2007). Erosive osteoarthritis of the feet: Description of two patients. Joint Bone Spine. 74(3). 296–298. 6 indexed citations
18.
Más, Antonio Juan, et al.. (2006). Fractura de cadera patol gica. 15(5). 107–107.
19.
Más, Antonio Juan, Juan Rodés, Miquel Lozano, et al.. (2001). Soporte hepático bioartificial en la insuficiencia hepática aguda grave. Primer caso tratado en España. Medicina Clínica. 117(20). 781–784. 2 indexed citations
20.
Martı́n-Granizo, Rafael, et al.. (1999). Pneumoparotid in childhood: Report of two cases. Journal of Oral and Maxillofacial Surgery. 57(12). 1468–1471. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bilge Başakçı Çalık Breakdown of academic impact, for papers by Avis Ware Breakdown of academic impact, for papers by Samantha Stephens Breakdown of academic impact, for papers by Cheryl L. Wright Breakdown of academic impact, for papers by T. Schochat Breakdown of academic impact, for papers by Joaquim Esteve-Vives Breakdown of academic impact, for papers by Frank R. van Genderen Breakdown of academic impact, for papers by T.L González Breakdown of academic impact, for papers by Tasmania del Pino‐Sedeño Breakdown of academic impact, for papers by J F Haverman
Rankless by CCL
2026